Pay in 4 interest-free payments of $6.96 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Journey of siRNA: clinical developments and targeted delivery
With MASH/NASH has become the next hot button topic (1 in 3 adults with 1.8 billion affected by 2050), BI have staked their claim on this growing market
and Jeevaratnam, K
It's particularly effective for tendon, ligament, and gut healing
IIa for obesity from known starting point and SBDD press release / INN proposed names list Structure Therapeutics, South San Francisco, CA The recently released WHO INN proposed names list includes the structure and name of Structure Therapeutics oral small molecule GLP-1R agonist, aleniglipron (GSBR-1290)
US$ 25.45
US$ 26.79
:max_bytes(150000):strip_icc()/GettyImages-1758233726-9eb529f998844ee8adb39aeb580f0726.jpg)
US$ 22.76
US$ 23.87
US$ 27.80
US$ 25.92
US$ 21.01
US$ 25.79
US$ 27.09
US$ 22.00
